synendos

synendos

synendos

Synendos Therapeutics: Firstinclass endocannabinoid modulators to restore natural functioning of the brain in CNS disorders.
Founded
2019
Raised
$40k
Follow us
Twitter followers
Latest funding
$40,000
Seed fund - 2019
Venture Kick
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when synendos makes some noise.